glp-1 gallstones receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications Gallbladder Risks with GLP-1 Medications

Eligible patients in Maryland and Delaware may receive in-person or telehealth care based on their location and clinical needs Some patients notice changes in appetite during the first few doses, while others require gradual dose escalation before experiencing a meaningful effect

PMID: 26706022

The result is a lot of noise and not much clarity even among clinicians

doi: 10.2478/aiht-2018-69-2966

Exerts potent antioxidant and anti-inflammatory effects, reducing oxidative stress and supporting cellular repair throughout the body

SKIN INFECTIONS - the probability of occurrence of a skin abscess, necrosis, and blisters associated with pain and erythema is more so common in immunologically compromised patients and poorly controlled diabetes